Investment Rating - The report maintains a "Positive" investment rating for the cosmetics industry [3] Core Insights - The cosmetics industry is experiencing stable growth with a slight improvement in growth rates, while profitability continues to show differentiation among companies [11][16] - The average revenue growth rate for the cosmetics industry in Q1 and Q2 of 2025 was -8.4% and -2.1%, respectively, indicating a slight improvement in the second quarter [16] - Online sales channels, particularly Tmall and Douyin, have shown a year-on-year growth of 13.1% in the first half of 2025, reflecting a recovery in consumer demand [11] Summary by Sections Cosmetics: Stable Growth and Business Adjustments - The cosmetics industry showed a year-on-year growth of 3.1% and 2.6% in Q1 and Q2 of 2025, respectively, with a significant improvement compared to the -1.1% growth in 2024 [11] - The industry is characterized by a slight improvement in growth rates, with the overall growth falling into a stable range [11] Revenue: Differentiation Among Brands - The average revenue growth for the brand segment was 0.4% and 6.5% in Q1 and Q2 of 2025, respectively, indicating stronger resilience compared to upstream and downstream segments [16] - Mid-sized brands like Maogeping and Shangmei have achieved good growth amidst a stable industry backdrop, while leading companies like Proya continue to grow steadily [16] Gross Margin Trends - The average gross margin for the brand segment increased by 1.6 percentage points in the first half of 2025, driven by improved business structures and effective price control by certain brands [21] - Specific brands like Water Sheep and Beitaini have seen significant improvements in gross margins due to product upgrades and price management strategies [21] Product Innovation: Focus on Core Series and Efficacy Expansion - Brands are focusing on upgrading core product lines and expanding efficacy categories, particularly in sunscreen and whitening, with increased competition expected [25] - New product launches include Proya's whitening series and Beitaini's anti-aging products, indicating a trend towards enhancing product offerings [25] Sales Expenses: Rising Industry Rates - The average sales expense ratio for brands in the first half of 2025 was 44.7%, reflecting a year-on-year increase of 1.7 percentage points, influenced by rising competition and platform costs [31] - The narrowing of gross sales margins indicates ongoing pressure on profitability across the industry [31]

Core Viewpoint - Morgan Stanley reports that Shiseido's performance in the first half of the year is robust, with the company aiming to become the leading cosmetics group in China and one of the top ten globally [1] Group 1: Company Strategy - The company's strategy is clear, focusing on cosmetics and developing a multi-brand approach that encompasses six major categories while promoting globalization [1] - Morgan Stanley is optimistic about the company's long-term development and has raised its profit forecasts for 2025-2027 [1] Group 2: Market Outlook - The target price for Shiseido is set at 114 HKD, with a maintained "buy" rating [1] - The report suggests that Shiseido is likely to benefit from the growth of the Chinese cosmetics market and the trend towards local brands [1] - The company is expected to further expand its market share due to its multi-brand strategy, research and development capabilities, omnichannel approach, and brand value advantages [1]

该行将上美股份2025至2027年预测盈利上调1%至5%，预估较市场共识高出3%至8%。基于现金流折现 率作估值，给予新目标价为114港元，暗示2026至2027年预测市盈率分别为30倍及24倍，维持"增持"评 级。摩通预期，上美股份将承载中国化妆品行业的快速成长，及本土自豪趋势，进一步扩大市场份额， 凭借其成功的多品牌组合、稳健的研发、完善的全渠道布局及不断提升的品牌价值。 摩根大通发表研究报告指，上美股份今年上半年业绩稳健，对其长期愿景感到鼓舞，因其目标是成为国 内第一大化妆品集团，及全球十大化妆品集团之一。公司拥有清晰的战略路线图，包括专注单一领域 (化妆品)、多品牌(涵盖六大类别，包括大众护肤、母婴护理、盥洗用品、彩妆、功能性护肤及高端护 肤)及全球化；凭借其品牌业务单位自主结构及激励的人才团队，摩通对公司的长期愿景持乐观态度。 ...

智通财经APP获悉，摩根大通发布研报称，根据现金流量折现法(DCF)予上美股份(02145)最新目标价为 114港元，对应2026/27年30倍及24倍市盈率，维持"增持"评级。该行预计，集团将凭借多品牌组合、研 发实力、全渠道和不断提升的品牌价值，以及随着内地美妆行业快速增长，将进一步提升市场份额。 2025年上半年集团业绩稳健，该行对集团的长期愿景持乐观态度。该行将2025-27年盈利预测上调1- 5%，较市场普遍预期高出3-8%。 ...

摩根大通发布研报称，根据现金流量折现法(DCF)予上美股份(02145)最新目标价为114港元，对应 2026/27年30倍及24倍市盈率，维持"增持"评级。该行预计，集团将凭借多品牌组合、研发实力、全渠 道和不断提升的品牌价值，以及随着内地美妆行业快速增长，将进一步提升市场份额。2025年上半年集 团业绩稳健，该行对集团的长期愿景持乐观态度。该行将2025-27年盈利预测上调1-5%，较市场普遍预 期高出3-8%。 ...

北京商报讯（记者 张君花）9月11日，北京商报记者了解到，上美股份宣布全球多肽美容科技开创者 Karl Lintner博士正式出任上美股份科学委员会首席科学顾问。根据公开资料，Karl Lintner博士就读于奥 地利维也纳大学的生物化学专业，专注研究胜肽三十多年，是全球首位将肽专利技术引入化妆品应用领 域的科学家。上美股份表示，Karl Lintner博士的加入，将为上美全球多肽技术布局提供前瞻性指导，为 上美科研团队提供技术建议与解决方案，与此同时，Karl Lintner博士也将作为上美全球化科研生态的重 要推动者，帮助上美股份对接国际顶尖科研机构和学术组织，建立跨国研发合作平台，促进全球优质科 研资源的整合与共享。 ...

Core Insights - The appointment of Dr. Karl Lintner as the Chief Scientific Advisor of Up Beauty marks a significant step in the company's global research and development strategy, integrating global scientific expertise with local market insights [3][10]. Group 1: Dr. Karl Lintner's Background and Role - Dr. Lintner is recognized as a pioneer in peptide technology within the cosmetics industry, having a PhD in biochemistry from the University of Vienna and over ten years of experience in peptide research [4][5]. - His contributions include successfully introducing peptide patent technology into cosmetics, transforming the beauty technology landscape [5][11]. - Lintner's collaboration with Up Beauty aligns with the company's vision of building a global research framework, enhancing its international cooperation capabilities [5][9]. Group 2: Strategic Implications for Up Beauty - The partnership with Dr. Lintner is expected to enhance Up Beauty's global competitiveness in peptide technology, providing a platform for innovation and collaboration with top international research institutions [13][14]. - This collaboration signifies a shift in the Chinese beauty industry towards a more systematic approach to research and development, moving from passive technology acquisition to proactive collaboration [16][17]. - Up Beauty aims to establish a "Chinese Original Ingredient" certification system, enhancing its role in setting industry standards and increasing its global influence [18][19]. Group 3: Market Context and Future Outlook - The Chinese beauty market is experiencing a surge in demand for effective products, positioning Up Beauty as a leader in connecting technological advancements with consumer needs [9][10]. - The collaboration is anticipated to accelerate the development of innovative peptide-based products, setting a benchmark for domestic brands in the anti-aging segment [11][13]. - The integration of global scientific insights with local market understanding is expected to elevate China's position in the global beauty research landscape [19][20].

Core Insights - The appointment of Dr. Karl Lintner as the Chief Scientific Advisor marks a significant step in the global R&D strategy of the company, enhancing its capabilities in peptide research and development in the beauty industry [1][2][3] Group 1: Dr. Karl Lintner's Background and Role - Dr. Lintner is recognized as a pioneer in peptide technology within the cosmetics industry, having successfully introduced peptide patent technology into cosmetic applications, which transformed global beauty technology [2][3] - His role will include providing forward-looking planning for the company's global peptide technology layout, assisting in building international research cooperation platforms, and integrating global high-quality research resources [6][7] Group 2: Strategic Importance of the Appointment - The collaboration signifies a shift in the Chinese beauty industry towards systematic competitiveness, moving from passive technology acquisition to proactive collaboration with top international scientists [7][8] - The partnership aims to establish a "Chinese Original Ingredient" certification system, enhancing the company's ability to set industry standards and improve its global influence in beauty technology [8] Group 3: Market Context and Opportunities - The Chinese beauty market is experiencing a surge in demand for efficacy-driven products, which aligns with the company's multi-brand strategy and market foundation, positioning it as a strong platform for technological breakthroughs [3][4] - The long-term investment in peptide research by the company has allowed it to catch up with international competitors, establishing a significant presence in the anti-aging segment [5][6]

Core Insights - The appointment of Dr. Karl Lintner as the Chief Scientific Advisor marks a significant step in the global R&D strategy of the company, enhancing its capabilities in peptide research and beauty technology [1][3][4] Group 1: Strategic Developments - The collaboration with Dr. Lintner signifies a new phase in the company's global R&D strategy, integrating global scientific wisdom with local market insights to boost the Chinese peptide research and beauty industry [3][10] - Dr. Lintner, a pioneer in peptide technology, brings over 20 years of experience and has been instrumental in introducing peptide patent technology into cosmetics, revolutionizing the beauty technology landscape [4][11] Group 2: Research and Development - The company has established a scientific committee to support international collaborations, aiming to create a cross-disciplinary and borderless research community, which aligns with Dr. Lintner's mission to realize scientific value [5][10] - The partnership will facilitate the establishment of a multinational R&D cooperation platform, enhancing the integration of top-tier global research resources and fostering collaborative innovation [13][16] Group 3: Market Positioning - The Chinese beauty market's dynamic nature and the company's leadership position provide a fertile ground for Dr. Lintner's expertise, allowing for the rapid iteration of technology in response to consumer demand for effective products [10][15] - The collaboration is expected to elevate the company's global standing in the cosmetics industry, enabling it to transform scientific breakthroughs into market-ready products that cater to local consumer needs [10][18] Group 4: Industry Impact - This partnership is poised to shift the Chinese beauty industry from passive technology adoption to proactive collaboration, enhancing the global competitiveness of domestic brands [15][16] - The initiative aims to establish a "Chinese Original Ingredient" certification system, promoting advancements in peptide technology and setting new industry standards, thereby increasing China's influence in global beauty technology [16][18]

New Consumption - In August 2025, the GMV of the beauty category on Douyin exceeded 20 billion yuan, with a year-on-year growth of 19.56% and a month-on-month growth of 21.46% [2][7] - Domestic brands performed well, with Han Shu leading the market with a GMV exceeding 700 million yuan, and the Han Shu Hongman Waist Ring Six Peptide Set being the only product to exceed 100 million yuan in sales [7][8] - The trend in Douyin beauty consumption is shifting from "trial consumption" to "stable repurchase," indicating a more rational consumer behavior focusing on product practicality [8] Robotics Industry - The human-shaped robot market is expected to grow significantly, with the market size projected to reach approximately 27.6 billion yuan in 2024 and 750 billion yuan by 2029 [9][10] - Key components for human-shaped robots include actuators, sensors, and transmission systems, with the planetary roller screw expected to account for 19% of the total cost by 2030 [9][10] - Domestic companies are gradually breaking into the high-end bearing market, which is currently dominated by eight global enterprises, with a current localization rate of less than 20% [10][11] Food and Beverage Industry - National beer companies showed stable revenue and profit performance in the first half of 2025, with cost reductions contributing to gross profit growth [15][16] - The dairy sector is expected to see a reversal in fundamentals as raw milk prices stabilize and beef prices rise, which could enhance profitability for dairy companies [16] - The snack food sector is experiencing a divergence in performance, with emerging channels like bulk snacks and membership supermarkets maintaining high momentum, while traditional channels face challenges [17] Logistics Industry - Zhonggu Logistics reported a revenue of 5.338 billion yuan in the first half of 2025, a decrease of 6.99% year-on-year, but net profit increased by 41.59% to 1.072 billion yuan [19][20] - The company is optimizing its capacity deployment in response to domestic demand recovery and external trade needs, which supports profit growth [20][21] - The company plans to distribute 9.03 billion yuan in dividends, reflecting its strong profit attributes [21] Public Utilities and Environmental Protection - Datang New Energy achieved a revenue of 6.845 billion yuan in the first half of 2025, with a year-on-year growth of 3.26%, while net profit decreased by 4.37% [22][23] - The company’s capital expenditure significantly decreased, indicating a focus on optimizing financial structure [26][27] - The wind power sector is expected to outperform solar power in terms of output and operational cycles, with a favorable market environment anticipated for wind power operators [27]